Jump to content

Surly #Stonks


Wally Fairway

Recommended Posts

59 minutes ago, Blotto said:

They blow through 10X of that amount in operating expense in a year, and still have no revenue. Hell they just issued 14 million warrants in February. They either whore themselves out to their big pharma partner ASAP, or there will be massive dilution coming. This company is extremely fucking bloated with 725 employees and no revenue. By comparison sakes, RVPH manages to generate zero revenue with only 10 full time employees according to their latest annual report. 

Biotech is a bitch.

  • Hook 'Em 1
  • Rage+1 1
Link to comment
Share on other sites

6 hours ago, Blotto said:

They blow through 10X of that amount in operating expense in a year, and still have no revenue. Hell they just issued 14 million warrants in February. They either whore themselves out to their big pharma partner ASAP, or there will be massive dilution coming. This company is extremely fucking bloated with 725 employees and no revenue. By comparison sakes, RVPH manages to generate zero revenue with only 10 full time employees according to their latest annual report. 

RVPH has one compound they’re actively working on.  IBRX has 16 or 17 trials ongoing with several of them at late stage.  The FDA didn’t have issues with IBRX’s bladder cancer drug or the results.  I think IBRX’s CEO, Patrick Soon-Shiong, has a meeting w/FDA to find out exactly what needs to happen with the manufacturing facilities.  Then, he has to decide how much money and time that will take, so he can reapply for permission to market the drug.  Then, he’ll decide whether to foot the bill himself or partner w/big pharma before the drug gets approved.  Of course, he wants to partner >after< the bladder drug is approved to get full value.  My take is he’ll foot the bill himself (he’s already pumped $700 million into the company), wait for FDA approval, and, then, partner w/big pharma.  If something was seriously flawed with IBRX’s drug, the stock would be trading under a dollar…instead of where it was two weeks ago.  Finally, the real losers today are the patients who could’ve benefited from this medication.  The FDA should be completely gutted and retooled.

  • Rage+1 1
  • Drool 1
Link to comment
Share on other sites

11 hours ago, Harrison Stafford said:

RVPH has one compound they’re actively working on.  IBRX has 16 or 17 trials ongoing with several of them at late stage.  The FDA didn’t have issues with IBRX’s bladder cancer drug or the results.  I think IBRX’s CEO, Patrick Soon-Shiong, has a meeting w/FDA to find out exactly what needs to happen with the manufacturing facilities.  Then, he has to decide how much money and time that will take, so he can reapply for permission to market the drug.  Then, he’ll decide whether to foot the bill himself or partner w/big pharma before the drug gets approved.  Of course, he wants to partner >after< the bladder drug is approved to get full value.  My take is he’ll foot the bill himself (he’s already pumped $700 million into the company), wait for FDA approval, and, then, partner w/big pharma.  If something was seriously flawed with IBRX’s drug, the stock would be trading under a dollar…instead of where it was two weeks ago.  Finally, the real losers today are the patients who could’ve benefited from this medication.  The FDA should be completely gutted and retooled.

bang that drum
bang it hard
bang it loud 

  • Hook 'Em 1
  • Like 1
  • Haha 1
Link to comment
Share on other sites

Just got notice that my stop-loss for my RVPH shares kicked in at $7.75. Netted a nice 78% profit. Now I just have my 10 options contracts.

Went ahead and bought 10,000 shares of that mining exploration company, SKKRF, mentioned above. 5 minutes of research shows it does have legitimate players running it and it has financial backing from a $1B parent company.

Link to comment
Share on other sites

First Solar paid $80 million today for a European Solar tech company called Evolar that has produced cells with record high efficiency. FSLR is up 25%+ which equates to a $5 billion dollar increase in market cap. They should buy more of those. Seems like an over reaction, but what do I know. 

The increase pushes the P/E to a modest 525 on a $25B market cap. Fuck it, I'm in for July $200P @ $6.90. Added on, so my cost is now $7.00

 

Edited by Blotto
  • Like 1
Link to comment
Share on other sites

6 hours ago, Coelenterate Fuccboi said:

I don’t think that was the intent of all the drug prevention propaganda. The idea was to not use drugs.

DARE - to keep stonkers off drugs

Edited by KYHorn
Link to comment
Share on other sites

1 hour ago, closetohumping said:

Am I too late for the get rich scheme?

really it is quite easy 
a) buy stonks before they make it onto the Surly radar
b) sell the stonks into the rally as the Surly crew rushes into the void
c) profit
d) see step a)
rinse, wash, repeat

 

  • Hook 'Em 2
  • Like 1
  • Haha 1
Link to comment
Share on other sites

On 5/12/2023 at 11:11 AM, Blotto said:

First Solar paid $80 million today for a European Solar tech company called Evolar that has produced cells with record high efficiency. FSLR is up 25%+ which equates to a $5 billion dollar increase in market cap. They should buy more of those. Seems like an over reaction, but what do I know. 

The increase pushes the P/E to a modest 525 on a $25B market cap. Fuck it, I'm in for July $200P @ $6.90. Added on, so my cost is now $7.00

 

Sold em at a little over $12 for a ~70% profit. Probably left some meat on that bone, but I was just trying to capture a good chunk of the correction after last weeks spike. On to the next one. 

Edited by Blotto
  • Like 2
Link to comment
Share on other sites

1 hour ago, Blotto said:

Sold em at a little over $12 for a ~70% profit. Probably left some meat on that bone, but I was just trying to capture a good chunk of the correction after last weeks spike. On to the next one. 

You can never go broke taking profits
referenced - someone who invests, and doesn't stonkaround

  • Hook 'Em 1
Link to comment
Share on other sites

2 minutes ago, Wally Fairway said:

You can never go broke taking profits
referenced - someone who invests, and doesn't stonkaround

That aint no lie...I bought June IBRX $5 calls for $0.30. Right before the bed shitting, they were over $2.00 and together with the runup in the stock I was back to break even overall. I thought I still had a week or two before the FDA decision and had a sell in for $2.40. I did not have a "week or two" and they are now worth .05/.10 lulz. 

Link to comment
Share on other sites

2 minutes ago, Blotto said:

That aint no lie...I bought June IBRX $5 calls for $0.30. Right before the bed shitting, they were over $2.00 and together with the runup in the stock I was back to break even overall. I thought I still had a week or two before the FDA decision and had a sell in for $2.40. I did not have a "week or two" and they are now worth .05/.10 lulz. 

It took me longer than it should have to realize that I'm playing with options not to buy/sell at the strike price but hopefully to make money - so I sell them into a profit position and don't worry if money there is left on the table. Because more often than I like to remember I have seen all the value in them dry up almost overnight.

Link to comment
Share on other sites

54 minutes ago, Wally Fairway said:

You can never go broke taking profits
referenced - someone who invests, and doesn't stonkaround

I take the opposite approach to investing ( no stonks) Cut your losers and let your winners run. 

Edited by TonyTexas
  • Hook 'Em 1
Link to comment
Share on other sites

On 5/12/2023 at 9:46 AM, Harrison Stafford said:

RVPH order filled at 7.60 for 3000 shares.  Now own 9000 shares of RVPH.  Placed GTC orders for 3000 more at 7.03 and another 3000 at 6.60.

Filled the 3000 share RVPH  order at 7.03.  Now have 12,000 shares of RVPH.  Have one GTC buy left at 6.60.  Wouldn’t bother me at all if that order never fills.

Link to comment
Share on other sites

On 5/22/2023 at 4:43 PM, Harrison Stafford said:

Filled the 3000 share RVPH  order at 7.03.  Now have 12,000 shares of RVPH.  Have one GTC buy left at 6.60.  Wouldn’t bother me at all if that order never fills.

Filled the last 3000 share order at 6.60 bringing the total position to 15,000 shares of RVPH.  Es todo.

  • Hook 'Em 1
Link to comment
Share on other sites

On 5/25/2023 at 4:44 PM, bluto said:

Hi ALPP with your sweet ass reverse split that you’ll never ever ever recover from. Write offs for years boys!

Thankfully - I partially exited that as it marched past $7 (now past $65; split adjusted) and got out of the rest on the way down. This is still the best #stonk that I traded in/out of, but only because I got all the way out - and still I regret that my first purchase was at about $0.075 in June 2020, took a loss on that in Sept 2020 at $0.041 before getting back in early Dec 2020 for about $1. Had I kept those first $25,000 shares  It was a great ride - thanks @RCRanger03 most of the money I have in other #stonks is still from that initial success.

  • Hook 'Em 3
  • Like 1
Link to comment
Share on other sites

11 minutes ago, KYHorn said:

https://recyclico.com/recyclico-battery-materials-and-zenith-chemical-announce-a-us25-million-lithium-ion-battery-recycling-joint-venture-in-taiwan/&nbsp;

RecycLiCo Battery Materials and Zenith Chemical Announce a US$25 Million Lithium-ion Battery Recycling Joint Venture in Taiwan 

bounce dead cat, bounce
(this is my largest holding.....if you use the metric of most number of shares)

Link to comment
Share on other sites

28 minutes ago, KYHorn said:

https://recyclico.com/recyclico-battery-materials-and-zenith-chemical-announce-a-us25-million-lithium-ion-battery-recycling-joint-venture-in-taiwan/&nbsp;

RecycLiCo Battery Materials and Zenith Chemical Announce a US$25 Million Lithium-ion Battery Recycling Joint Venture in Taiwan 

It’s a start.  Holding 125,000 shares bought at .85.  

  • Hook 'Em 1
Link to comment
Share on other sites

Quote

During the fiscal year ended July 31, 2022, the Company recorded $6,191,384 in share-based payments expense (2021 – $11,383,322) due to the vesting of options granted during fiscal 2022, 2021 and 2020 and amendment of certain options previously granted. Additional detail on the financings is set out below under “Liquidity and Capital Resources”. Wages and benefits in the amount of $571,519 (2021 – $354,790) were recorded for the fiscal year ended July 31, 2022. 

That came from the last financial update on their website (https://recyclico.com/wp-content/uploads/2023/04/AMY-MDA-1-31-2023-final.pdf).  How many people can realistically even work at this joint? 

https://www.linkedin.com/company/recyclico-battery-materials-inc/people/

There is exactly one person on that page that seems to have a science background. I bailed on this one last year when I came to the realization that it wasn't serious about being a business. They have been around since 1987 and have managed to hang around all this time generating no revenue. Its impressive really. 

 

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.



×
×
  • Create New...